Enzo BML-SE181-0010 MMP-7 (catalytic domain) (human), (recombinant) (10 µg)
| Activity | Preincubation of MMP-7 catalytic domain at 19nM with the broad-spectrum inhibitor GM6001 (Prod. No. BML-EI300) at 100nM for 1 hour completely inhibits enzymatic activity. |
|---|---|
| Alternative Name | Matrix metalloproteinase 7, Matrilysin, Pump |
| Application Notes | Useful tool to study enzyme kinetics, cleave target substrates, and screen for inhibitors. |
| Formulation | Liquid. In 50 mM Tris-HCl pH 7.5, 5 mM CaCl2, 300 mM NaCl, 20 µM ZnCl2, 0.5% Brij-35, and 30% glycerol. |
| MW | 20.4 kDa |
| Purity | ≥95% (SDS-PAGE) |
| Purity Detail | Purified by multi-step chromatography. |
| Source | Produced in E. coli. Active Matrix Metalloproteinase-7 (MMP-7, matrilysin, pump) catalytic domain from human cDNA. The enzyme consists of the catalytic domain of human MMP-7 (Tyr95-Lys267, NM_002423) with a C-terminal purification tag. |
| Specific Activity | ≥200 pmol/min/µg at 37°C using the colorimetric thiopeptolide Ac-Pro-Leu-Gly-S-Leu-Leu-GlyOEt (100 µM; Prod. No. BML-P125) as substrate. |
| UniProt ID | P09237 |
| Long Term Storage | -80°C |
| Shipping | Dry Ice |
| Brand | Enzo |
|---|---|
| UNSPSC | 12352202 |